Transaction · 0001357550-26-000033

Weiss Asset Management LP

Weiss Asset Management LP, 10%, reported a transaction classified as other at Theravance Biopharma, Inc. involving 7457060.000000 shares for an estimated $126770020.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

otherSEC transaction code J10%
TBPHTheravance Biopharma, Inc.
Filing timeSep 28
Trade dateSep 23, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$17.03
Pre-filing
1mo ago -0.1%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

TBPH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TBPH since 2026-09-28Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
other
Code J
Identifier
0001357550-26-000033
Ordinary Share $0.00001 Par Value
Transaction date
Sep 23, 2026
Filed Sep 28, 2026, 07:20 PM · 5d delay
Shares
7.45M sh
$17.00 per share
Estimated value
-$126M
Computed from shares × price
Holdings after
0 sh
Indirect · See Footnote 2

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% NoOther Yes
Footnotes & amended
  1. F1

    On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. ("Parent"), and Zymeworks Merger Sub…

  2. F2

    Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss…

  3. F3

    Represents the cash portion of the consideration paid to shareholders upon the closing of the Merger.

Original filing · 0001357550-26-000033
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TBPH